Clinical Trial Update: Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Dakin's Solution to prevent radiation dermatitis in patients with breast cancer undergoing radiation therapy has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiation Dermatitis

Drugs mentioned

• Dakin's Solution (sodium hypochlorite solution)

Snippet

Sponsor: Stanford University | Conditions: Breast Cancer, Skin Reactions Secondary to Radiation Therapy | Phase 2 | Status: COMPLETED | Results posted: 2017-07-26